MeiraGTx
MGTX
$8.07
Share price
-1.94%
Change (1 day)
64.02%
Change (1 year)
MeiraGTx (MGTX) - Cash on Hand
Cash on Hand as of March 2025 : $66.52 Million USD
According to MeiraGTx's latest financial reports the company has $66.52 Million USD in cash and cash equivalents.
A company’s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
MeiraGTx - Cash on Hand chart (from 2017 to 2025)
Cash on Hand by year
| Year | Cash on Hand | Change |
|---|---|---|
| 2024-12-31 | $0.10 B | -20% |
| 2023-12-31 | $0.12 B | 12.16% |
| 2022-12-31 | $0.11 B | -16.11% |
| 2021-12-31 | $0.13 B | -34.28% |
| 2020-12-31 | $0.20 B | -7.8% |
| 2019-12-31 | $0.22 B | 233.77% |
| 2018-12-31 | $68.08 M | 696.39% |
| 2017-12-31 | $8.54 M | -51.09% |
| 2016-12-31 | $17.47 M |
Cash on Hand for similar companies or competitors
| Company | Cash on Hand | differencediff. | Country |
|---|---|---|---|
 Novocure
NVCR | $0.92 B | 1,296.71% | Jersey |
 Novavax NVAX | $0.73 B | 999.59% | 🇺🇸 USA |
 Organovo ONVO | $11.31 M | -83.00% | 🇺🇸 USA |
 Orchard Therapeutics
ORTX | $0.12 B | 88.53% | 🇬🇧 UK |